Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Bison carry seed across thousands of miles when they eat the grass, and then they move the seed up to other parts of the ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

The American Society for Reproductive Medicine published a report that concludes preimplantation genetic testing for ...

Technologies at the Advanced Rodent Transgenics Laboratory include genome editing design and implementation and transgenic ...

On November 3 of last year, the Department of Homeland Security (DHS) proposed a rule change allowing its agents to gather ...

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Funding supports safety studies, manufacturing and clinical planning needed before applying to test the treatment in patients ...

CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...

By Exec Edge Editorial Staff Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends ...

Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.

Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...